Quarterly report [Sections 13 or 15(d)]

Stock-based Compensation (Tables)

v3.26.1
Stock-based Compensation (Tables)
 6 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Restricted Stock Awards and Restricted Stock Units
Restricted Stock Awards (“RSAs”)
Restricted Stock Awards Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at October 1, 2025 8,750 $ 37.82 
Vested (8,750) (37.82)
Outstanding at March 31, 2026 — $ — 
On December 23, 2024, the Company granted MRSUs to one of its executives, which will be eligible to be earned if at any time prior to September 30, 2027, the average 30-day closing per share price of the Company’s Common Stock exceeds the applicable price per share thresholds set forth below:

Price Per Share Threshold
Number of MRSUs Earned
$35 per share
 5,000
$40 per share
 12,500
$45 per share
 20,500
Market-based Restricted Stock Units Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at October 1, 2025 38,000  $ 12.32 
Outstanding at March 31, 2026 38,000 $ 12.32 
a.The weighted average remaining contractual term is 1.5 years and the aggregate intrinsic value of MRSUs expected to vest is $1,568.
Schedule of Share-Based Payment Arrangement, Option
Stock Option Grants
Number of
Options		 Weighted
Average
Exercise
Price		 Weighted
Average
Remaining
Contractual
Term
(years)		 Aggregate
Intrinsic
Value
(in thousands)
Vested & Outstanding - October 1, 2025 36,500 $ 33.74 
Exercised (8,000) 33.96 
Forfeitures/expired (1,500) 33.96 
Vested and outstanding - March 31, 2026 27,000 $ 33.66  0.8 1,114
Schedule of Share-Based Payment Award, Valuation Assumptions
The assumptions used in the Monte Carlo simulation model to calculate the fair value of the Company’s MRSUs on the grant date are as follows:

Expected volatility of stock price 33.14  %
Risk-free interest rate 4.26  %
Expected term of awards (years) 2.77
Dividend yield 0.76  %
Grant date stock price $ 26.15